Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma
| Conditions: | Lung Cancer|Malignant Mesothelioma |
| Start Date: | August 1, 1997 |
| Phase: | Phase I |
| Status: | Completed |
| NCT ID: | NCT00003974 |
| Study Type: | Interventional |
| Intervention: | Biological: lung tumor associated antigen|Drug: DetoxPC|Drug: chemotherapy|Drug: cyclophosphamide |
| Study Design: | Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Roswell Park Cancer Institute |
| Ages: | Adult|Senior |
| Enrollment: | 20 |
| Funded By: | Other |
| First Received: | November 1, 1999 |
| End Date: | November 1, 2000 |
| Last Updated: | September 16, 2010 |
| Last Verified: | September 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
